{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:42:41Z","timestamp":1790808161608,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7844","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,2,4]]},"DOI":"10.1038\/s41586-020-03075-w","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T12:02:49Z","timestamp":1608724969000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Mechanism of EBV inducing anti-tumour immunity and its therapeutic use"],"prefix":"10.1038","volume":"590","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-4782","authenticated-orcid":false,"given":"Il-Kyu","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Dereck W.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-4669","authenticated-orcid":false,"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-1161","authenticated-orcid":false,"given":"Baochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"3075_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrc3670","volume":"14","author":"PG Coulie","year":"2014","unstructured":"Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14, 135\u2013146 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"3075_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrc3246","volume":"12","author":"T Blankenstein","year":"2012","unstructured":"Blankenstein, T., Coulie, P. G., Gilboa, E. & Jaffee, E. M. The determinants of tumour immunogenicity. Nat. Rev. Cancer 12, 307\u2013313 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"3075_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood-2008-12-194043","volume":"114","author":"HM Long","year":"2009","unstructured":"Long, H. M. et al. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein\u2013Barr virus-transformed B cells. Blood 114, 807\u2013815 (2009).","journal-title":"Blood"},{"key":"3075_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/2326-6066.CIR-13-0125","volume":"2","author":"UK Iheagwara","year":"2014","unstructured":"Iheagwara, U. K. et al. Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance. Cancer Immunol. Res. 2, 263\u2013273 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"3075_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B. & Hislop, A. D. The immunology of Epstein\u2013Barr virus-induced disease. Annu. Rev. Immunol. 33, 787\u2013821 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"3075_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2011.12.031","volume":"148","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. Immune surveillance and therapy of lymphomas driven by Epstein\u2013Barr virus protein LMP1 in a mouse model. Cell 148, 739\u2013751 (2012).","journal-title":"Cell"},{"key":"3075_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1101\/sqb.2013.78.020222","volume":"78","author":"T Yasuda","year":"2013","unstructured":"Yasuda, T. et al. Studying Epstein\u2013Barr virus pathologies and immune surveillance by reconstructing EBV infection in mice. Cold Spring Harb. Symp. Quant. Biol. 78, 259\u2013263 (2013).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"3075_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.1090148","volume":"302","author":"EL Pearce","year":"2003","unstructured":"Pearce, E. L. et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041\u20131043 (2003).","journal-title":"Science"},{"key":"3075_CR9","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1073\/pnas.1713607115","volume":"115","author":"IK Choi","year":"2018","unstructured":"Choi, I. K. et al. Signaling by the Epstein\u2013Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc. Natl Acad. Sci. USA 115, E686\u2013E695 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR10","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1182\/blood-2009-02-203687","volume":"113","author":"C Smith","year":"2009","unstructured":"Smith, C. et al. Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation. Blood 113, 6148\u20136152 (2009).","journal-title":"Blood"},{"key":"3075_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.iy.13.040195.002331","volume":"13","author":"H Acha-Orbea","year":"1995","unstructured":"Acha-Orbea, H. & MacDonald, H. R. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13, 459\u2013486 (1995).","journal-title":"Annu. Rev. Immunol."},{"key":"3075_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson, D. A. Epstein\u2013Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1, 75\u201382 (2001).","journal-title":"Nat. Rev. Immunol."},{"key":"3075_CR13","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","volume":"92","author":"JL Schultze","year":"1995","unstructured":"Schultze, J. L. et al. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc. Natl Acad. Sci. USA 92, 8200\u20138204 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR14","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","volume":"90","author":"KM Kaye","year":"1993","unstructured":"Kaye, K. M., Izumi, K. M. & Kieff, E. Epstein\u2013Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA 90, 9150\u20139154 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","volume":"112","author":"P Muranski","year":"2008","unstructured":"Muranski, P. et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112, 362\u2013373 (2008).","journal-title":"Blood"},{"key":"3075_CR16","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.88.8.3290","volume":"88","author":"A Brooks","year":"1991","unstructured":"Brooks, A. et al. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc. Natl Acad. Sci. USA 88, 3290\u20133294 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR17","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.0501190102","volume":"102","author":"J Dengjel","year":"2005","unstructured":"Dengjel, J. et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl Acad. Sci. USA 102, 7922\u20137927 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1104904","volume":"307","author":"C Paludan","year":"2005","unstructured":"Paludan, C. et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593\u2013596 (2005).","journal-title":"Science"},{"key":"3075_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi, M. et al. Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728\u2013740 (2011).","journal-title":"Cancer Cell"},{"key":"3075_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","volume":"36","author":"MGM Roemer","year":"2018","unstructured":"Roemer, M. G. M. et al. Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma. J. Clin. Oncol. 36, 942\u2013950 (2018).","journal-title":"J. Clin. Oncol."},{"key":"3075_CR21","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.4049\/jimmunol.178.11.6840","volume":"178","author":"KG Elpek","year":"2007","unstructured":"Elpek, K. G., Lacelle, C., Singh, N. P., Yolcu, E. S. & Shirwan, H. CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model. J. Immunol. 178, 6840\u20136848 (2007).","journal-title":"J. Immunol."},{"key":"3075_CR22","doi-asserted-by":"publisher","first-page":"E166","DOI":"10.1073\/pnas.1416389112","volume":"112","author":"DJ Kowalewski","year":"2015","unstructured":"Kowalewski, D. J. et al. HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). Proc. Natl Acad. Sci. USA 112, E166\u2013E175 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3075_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","volume":"32","author":"CM Bollard","year":"2014","unstructured":"Bollard, C. M. et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein\u2013Barr virus latent membrane proteins. J. Clin. Oncol. 32, 798\u2013808 (2014).","journal-title":"J. Clin. Oncol."},{"key":"3075_CR24","doi-asserted-by":"publisher","first-page":"e1004746","DOI":"10.1371\/journal.ppat.1004746","volume":"11","author":"S Jayasooriya","year":"2015","unstructured":"Jayasooriya, S. et al. Early virological and immunological events in asymptomatic Epstein\u2013Barr virus infection in African children. PLoS Pathog. 11, e1004746 (2015).","journal-title":"PLoS Pathog."},{"key":"3075_CR25","doi-asserted-by":"publisher","first-page":"e1005286","DOI":"10.1371\/journal.ppat.1005286","volume":"11","author":"SK Dunmire","year":"2015","unstructured":"Dunmire, S. K., Grimm, J. M., Schmeling, D. O., Balfour, H. H., Jr & Hogquist, K. A. The incubation period of primary Epstein\u2013Barr virus infection: viral dynamics and immunologic events. PLoS Pathog. 11, e1005286 (2015).","journal-title":"PLoS Pathog."},{"key":"3075_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fimmu.2014.00174","volume":"5","author":"OA Haabeth","year":"2014","unstructured":"Haabeth, O. A. et al. How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules? Front. Immunol. 5, 174 (2014).","journal-title":"Front. Immunol."},{"key":"3075_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.celrep.2015.03.059","volume":"11","author":"B Zhang","year":"2015","unstructured":"Zhang, B. et al. An oncogenic role for alternative NF-\u03baB signaling in DLBCL revealed upon deregulated BCL6 expression. Cell Rep. 11, 715\u2013726 (2015).","journal-title":"Cell Rep."},{"key":"3075_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","volume":"132","author":"SB Koralov","year":"2008","unstructured":"Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860\u2013874 (2008).","journal-title":"Cell"},{"key":"3075_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jim.2005.06.005","volume":"304","author":"L He","year":"2005","unstructured":"He, L. et al. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells. J. Immunol. Methods 304, 43\u201359 (2005).","journal-title":"J. Immunol. Methods"},{"key":"3075_CR30","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1182\/blood-2014-10-609271","volume":"125","author":"Y Cui","year":"2015","unstructured":"Cui, Y. et al. Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL. Blood 125, 2958\u20132967 (2015).","journal-title":"Blood"},{"key":"3075_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/cncr.22958","volume":"110","author":"S Yamaguchi","year":"2007","unstructured":"Yamaguchi, S. et al. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Cancer 110, 1469\u20131477 (2007).","journal-title":"Cancer"},{"key":"3075_CR32","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JVI.02034-13","volume":"88","author":"F Porichis","year":"2014","unstructured":"Porichis, F. et al. Differential impact of PD-1 and\/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions. J. Virol. 88, 2508\u20132518 (2014).","journal-title":"J. Virol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03075-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:01:58Z","timestamp":1684605718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-03075-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":32,"journal-issue":{"issue":"7844","published-print":{"date-parts":[[2021,2,4]]}},"alternative-id":["3075"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-03075-w","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"10 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This Article was amended to correct the Peer review information, which was originally incorrect.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.-K.C., Z.W. and B.Z. are inventors on patent applications that cover parts of this work; Z.H. is a current employee of ElevateBio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}